Edition:
United States

Profile: Recordati Industria Chimica e Farmaceutica SpA (RECI.MI)

RECI.MI on Milan Stock Exchange

26.96EUR
26 Aug 2016
Change (% chg)

€0.03 (+0.11%)
Prev Close
€26.93
Open
€27.07
Day's High
€27.09
Day's Low
€26.64
Volume
210,993
Avg. Vol
449,678
52-wk High
€29.74
52-wk Low
€18.80

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA and Pro Farma AG.

Company Address

Recordati Industria Chimica e Farmaceutica SpA

Via M. Civitali, 1
MILANO     20148
P: +3902.487871
F: +3902.40073747

Company Web Links